Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series

BMC Nephrology

Table 2 Outcomes of patients treated with rituximab

Patient	Rituximab scheme	CrCl^a	Follow up (months)	Leukopenia	Infection	Dialysis	Rituximab maintainance therapy	VDI score^b
1	375 mg/m² weeklyx4	27	22	No	no	no	yes	4
2	1000 mgx2	NA^c	72	No	no	yes	no	2
3	375 mg/m² weeklyx4	21	7	No	yes	no	no	5
4	1000 mgx2	NA^c	8	Yes	no	yes	no	NA^c
5	375 mg/m² weeklyx4	NA^c	19	No	yes	yes	no	1
6	375 mg/m² weeklyx4	NA^c	11	Yes	yes	yes	yes	1
7	375 mg/m² weeklyx4	95	9	No	no	no	yes	2
8	375 mg/m² weeklyx4	20	12	No	no	no	yes	3

ISSN: 1471-2369